Cas:142246-48-8 4-chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole manufacturer & supplier

We serve Chemical Name:4-chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole CAS:142246-48-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole

Chemical Name:4-chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole
CAS.NO:142246-48-8
Synonyms:MFCD00191405;4-Chloro-7-chlorosulfonylbenzofurazan;4-Chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole;4-Chloro-2,1,3-benzoxadiazole-7-sulfonyl Chloride
Molecular Formula:C6H2Cl2N2O3S
Molecular Weight:253.06300
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:361.7ºC at 760 mmHg
Density:1.789g/cm3
Index of Refraction:1.638
PSA:81.44000
Exact Mass:251.91600
LogP:2.88450

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261
Packing Group:


Contact us for information like MFCD00191405 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Chloro-2,1,3-benzoxadiazole-7-sulfonyl Chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole Use and application,MFCD00191405 technical grade,usp/ep/jp grade.


Related News: After speaking to iRhythm on Tuesday, J.P. Morgan analysts wrote we shouldn’t expect an update on reimbursement before the release of the Physician Fee Schedule proposed rule in July/August. [2-(1(2)H-indazol-3-yloxy)-ethyl]-dimethyl-amine manufacturers “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. 1-(2,4-difluorophenyl)-7-(4-(ethylamino)piperidin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid suppliers Natural Biogenex, a 100 per cent subsidiary of Natural Capsules, is speeding up its efforts to manufacture active pharmaceutical ingredients (APIs) following the recent grant from Union government’s production linked incentive (PLI) scheme to offset the import dependence. (E)-3-(3,3-dimethyl-2-bicyclo[2.2.1]heptanyl)prop-2-enoic acid vendor & factory.